CONMED Corp 8-K

What Happened

• CONMED Corporation announced on June 3, 2026 that it entered into privately negotiated purchase agreements to repurchase approximately $645.2 million aggregate principal amount of its 2.25% Convertible Senior Notes due 2027.
• The company agreed to pay about $637.2 million in cash for the notes. These transactions are expected to close on June 15, 2026, subject to customary closing conditions. The form of the Purchase Agreement is filed as Exhibit 10.1 to the 8-K.

Key Details

• Instrument: 2.25% Convertible Senior Notes due 2027.
• Principal being repurchased: ≈ $645.2 million.
• Cash purchase price: ≈ $637.2 million (repurchase at a modest discount to principal).
• Agreement date and expected close: entered June 3, 2026; expected close June 15, 2026; privately negotiated with certain holders.

Why It Matters

• If completed, the transactions will reduce CONMED’s outstanding convertible debt by roughly $645.2M, which directly affects the company’s balance sheet and reported debt levels.
• The cash outlay (~$637.2M) represents a material use of liquidity and could influence near-term cash position and financing flexibility.
• Reducing convertible notes may also lower potential future dilution from conversions and reduce interest/convertible-related obligations tied to those notes.
• The purchases are subject to closing conditions; investors should watch for a closing announcement or further disclosures in company filings.